Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States.
about
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapyEfficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study.Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study.Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapyPCSK9 Inhibitors Show Value for Patients and the US Health Care System.
P2860
Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in cholesterol man ...... city across the United States.
@en
Differences in cholesterol man ...... city across the United States.
@nl
type
label
Differences in cholesterol man ...... city across the United States.
@en
Differences in cholesterol man ...... city across the United States.
@nl
prefLabel
Differences in cholesterol man ...... city across the United States.
@en
Differences in cholesterol man ...... city across the United States.
@nl
P2093
P2860
P1476
Differences in cholesterol man ...... city across the United States.
@en
P2093
Martin L Lee
Monica L Desnoyers
Stanley H Hsia
P2860
P304
P356
10.1016/J.JACL.2013.03.010
P407
P577
2013-04-03T00:00:00Z